JeffreyJ.PuMDPh.D.

Hematologic Oncology

Associate Professor of Medicine, Pathology, Pharmacology, and Biomedical Science Graduate Program, SUNY Upstate Medical University College of Medicine

Join to view full profile

Dr. Pu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pu's full profile

Already have an account?

Office
155 South Huntington Avenue
Boston, MA 02130
Phone+1 917-822-5065

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
New York Blood CenterFellowship, Blood Banking/Transfusion Medicine, 2006 - 2007
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2004 - 2006
Shanghai Jiao Tong University School of MedicineClass of 1987

Certifications & Licensure

MA State Medical License 2023 - 2026
NY State Medical License 2006 - 2025
SC State Medical License 2020 - 2025
AZ State Medical License 2020 - 2024
PA State Medical License 2012 - 2024
MD State Medical License 2008 - 2013
American Board of Internal Medicine Hematology

Clinical Trials

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011) Start of enrollment: 2012 May 01
Unknown status
Phase 1
Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma Start of enrollment: 2012 Nov 19
Completed
Phase 1

Publications & Presentations

PubMed

30 citations
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Anthony R. Mato, Nilanjan Ghosh, Stephen J. Schuster, Nicole Lamanna, John M. Pagel
Blood. 2021-05-20
80 citations
PD-1 pathway and its clinical application: A 20year journey after discovery of the complete human PD-1 gene.
Kristin Berger, Jeffrey J. Pu
Gene. 2018-01-05
46 citations
Paroxysmal Nocturnal Hemoglobinuria from Bench to Bedside
Jeffrey J. Pu, Robert A. Brodsky
Clinical and Translational Science. 2011-06-01

Abstracts/Posters

Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
Jeffrey J Pu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Remembering Thomas Brock, Xavier Becerra Confirmed as U.S. Health Secretary, and MoreJune 1st, 2021

Professional Memberships

American Society of Hematology - ASH
Member
American Society of Clinical Oncology - ASCO
Member
American Society for Blood and Marrow Transplantation
Member
American Association for Cancer Research - AACR
Member